Ionis Pharmaceuticals IONS announced that the FDA has granted the Breakthrough Therapy designation to its pipeline candidate, ION582, for the treatment of Angelman syndrome (AS), a rare neurological ...

Cidara Therapeutics CDTX announced that the FDA has granted a Breakthrough Therapy designation to its lead pipeline candidate, CD388, for the prevention of seasonal influenza. Shares of the company ...

Neuralink is currently conducting the first-in-human PRIME study (NCT06429735) in the US. Credit: Shutterstock/Kemarrravv13. · Medical Device Network · Shutterstock ...

Eli Lilly and Company LLY announced that the FDA has granted a Breakthrough Therapy designation to its novel folate receptor alpha (FRα) antibody-drug conjugate (ADC), sofetabart mipitecan (LY4170156) ...

Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening ...